FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Hybrid Pharma | 079665742 | 26436-5596 | 26436-5596-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5596 | 26436-5596-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5156 | 26436-5156-3 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5156 | 26436-5156-1 | Methionine; Inositol; Choline Chloride; Methylcobalamin | 25 mg/1 mL; 50 mg/1 mL; 50 mg/1 mL; 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5239 | 26436-5239-3 | Methylcobalamin | .5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5194 | 26436-5194-3 | Methylcobalamin | 300 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5015 | 26436-5015-3 | Methylcobalamin | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5055 | 26436-5055-3 | Methylcobalamin | 300 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5354 | 26436-5354-1 | Methylene Blue | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Hybrid Pharma | 079665742 | 26436-5001 | 26436-5001-5 | Ascorbic Acid | 500 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-931 | 68985-931-98 | Norepinephrine Bitartrate | 8 mg/250 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-012 | 68985-012-93 | Oxytocin | 30 U/500 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-112 | 68985-112-91 | Azithromycin Anhydrous | 2 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-004 | 68985-004-94 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-049 | 68985-049-91 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-629 | 68985-629-91 | Succinylcholine Chloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-324 | 68985-324-93 | Vancomycin Hydrochloride | 6 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-304 | 68985-304-92 | Vancomycin Hydrochloride | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-95 | Heparin Sodium | 10 U/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-540 | 68985-540-91 | Heparin Sodium | 10 U/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-153 | 68985-153-85 | Amiodarone Hydrochloride | 1.8 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| LEESAR INC | 025104311 | 68985-486 | 68985-486-93 | Lidocaine Hydrochloride Anhydrous; Lidocaine Hydrochloride | 20 mg/1 mL; 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | Atropine | .4 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | Potassium Cation | 149 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | Chloride Ion | 9 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | Chloride Ion | 234 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | Lidocaine | 20 mg/1 mL | 2023-2 | source_no_ndc | 2026-11-08 | |||
| McGuff Outsourcing Solutions | 134632103 | 67157-005 | 67157-005-30 | Procaine; Sodium Metabisulfite | 20 mg/30 mL; / | 2023-2 | valid | 2026-11-08 | |
| McGuff Outsourcing Solutions | 134632103 | 67157-135 | 67157-135-30 | Glutathione | 200 mg/30 mL | 2023-2 | valid | 2026-11-08 | |
| McGuff Outsourcing Solutions Inc. | 118884955 | 83343-005 | 83343-005-30 | Procaine | 20 mL/30 mL | 2023-2 | valid | 2026-11-08 | |
| McGuff Outsourcing Solutions Inc. | 118884955 | 83343-004 | 83343-004-15 | Edetate Calcium Disodium Trihydrate | 200 mg/15 mL | 2023-2 | valid | 2026-11-08 | |
| McGuff Outsourcing Solutions Inc. | 118884955 | 83343-135 | 83343-135-30 | Glutathione | 200 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1372 | 61141-1372-5 | Neostigmine Methylsulfate | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1418 | 61141-1418-1 | Phenylephrine Hydrochloride | 100 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-4538 | 61141-4538-4 | Povidone-Iodine | 50 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-4536 | 61141-4536-4 | Proparacaine Hydrochloride | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1370 | 61141-1370-5 | Ropivacaine Hydrochloride | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1351 | 61141-1351-1 | Succinylcholine Chloride | 20 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-4837 | 61141-4837-1 | Bupivacaine Hydrochloride; Fentanyl Citrate | 1.25 mg/1 mL; 2 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1374 | 61141-1374-5 | Ephedrine Sulfate | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1350 | 61141-1350-5 | Ephedrine Sulfate | 10 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 10 ug/1 mL | 2023-2 | valid | 2026-11-08 | |
| Medi-Fare Drug | 091326520 | 61141-1337 | 61141-1337-1 | Midazolam | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1014 | 70657-1014-3 | Glutathione | 200 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1223 | 70657-1223-3 | Methylcobalamin | 5 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| MedisourceRx | 055620221 | 70657-1013 | 70657-1013-3 | Methylcobalamin | 1 mg/1 mL | 2023-2 | valid | 2026-11-08 | |
| Molecular PharmaGroup | 080602630 | 72790-004 | 72790-004-05 | Dehydrated Alcohol | 2.1 mL/3 mL | 2023-2 | valid | 2026-11-08 | |
| Nubratori Inc. | 028707055 | 71300-6600 | 71300-6600-3 | Naltrexone Hydrochloride | 1.5 mg | 2023-2 | valid | 2026-11-08 |